BBVSX | VMVAX | BBVSX / VMVAX | |
Total Expense Ratio | 0.41 | 0.07 | 586% |
Annual Report Gross Expense Ratio | 0.68 | 0.07 | 971% |
Fund Existence | 10 years | 14 years | - |
Gain YTD | 7.887 | 7.964 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.52B | 32.5B | 26% |
Annual Yield % from dividends | 1.18 | 2.17 | 54% |
Returns for 1 year | 1.79 | 5.48 | 33% |
Returns for 3 years | 29.63 | 42.08 | 70% |
Returns for 5 years | 47.46 | 64.91 | 73% |
Returns for 10 years | 76.58 | 102.38 | 75% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NEFJX | 21.20 | 0.18 | +0.86% |
Natixis Vaughan Nelson Small Cap A | |||
HADUX | 79.65 | 0.32 | +0.40% |
Horizon Equity Premium Income Advisor | |||
VTMNX | 19.49 | N/A | N/A |
Vanguard Developed Markets Index Instl | |||
GCIAX | 17.87 | N/A | N/A |
Goldman Sachs Intl Eq Insghts A | |||
DNLRX | 65.05 | N/A | N/A |
BNY Mellon Active MidCap I |